UnitedHealth Group Incorporated (NYSE:UNH) had its price objective increased by investment analysts at Citigroup Inc. from $213.00 to $235.00 in a research note issued on Wednesday. The firm presently has a “buy” rating on the healthcare conglomerate’s stock. Citigroup Inc.’s target price would indicate a potential upside of 15.26% from the company’s previous close.

Several other equities research analysts have also issued reports on the company. Cantor Fitzgerald reiterated an “overweight” rating and set a $208.00 price target on shares of UnitedHealth Group in a report on Friday, July 21st. ValuEngine upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Friday, September 1st. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Oppenheimer Holdings, Inc. reiterated an “outperform” rating and set a $205.00 price target (up from $203.00) on shares of UnitedHealth Group in a report on Friday, July 21st. Finally, BidaskClub lowered UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a report on Wednesday, July 19th. Three equities research analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the company’s stock. UnitedHealth Group currently has a consensus rating of “Buy” and a consensus target price of $211.31.

UnitedHealth Group (NYSE:UNH) opened at 203.89 on Wednesday. The stock’s 50 day moving average is $196.56 and its 200 day moving average is $184.87. The stock has a market capitalization of $197.13 billion, a price-to-earnings ratio of 24.49 and a beta of 0.63. UnitedHealth Group has a one year low of $133.03 and a one year high of $206.62.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, topping the Zacks’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The firm had revenue of $50.32 billion during the quarter, compared to analyst estimates of $50.38 billion. During the same period last year, the company posted $2.17 EPS. The business’s quarterly revenue was up 8.7% compared to the same quarter last year. On average, equities analysts forecast that UnitedHealth Group will post $9.87 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “UnitedHealth Group Incorporated (UNH) Given New $235.00 Price Target at Citigroup Inc.” was originally posted by American Banking News and is owned by of American Banking News. If you are reading this piece of content on another domain, it was illegally stolen and reposted in violation of international copyright & trademark law. The original version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/10/18/unitedhealth-group-incorporated-unh-given-new-235-00-price-target-at-citigroup-inc.html.

In other news, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction that occurred on Thursday, August 3rd. The stock was sold at an average price of $193.98, for a total transaction of $969,900.00. Following the sale, the director now directly owns 76,058 shares in the company, valued at $14,753,730.84. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Richard T. Burke sold 15,000 shares of the business’s stock in a transaction that occurred on Monday, August 21st. The shares were sold at an average price of $191.71, for a total value of $2,875,650.00. Following the sale, the director now owns 1,818,898 shares in the company, valued at $348,700,935.58. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 76,174 shares of company stock worth $14,981,909. Company insiders own 0.89% of the company’s stock.

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Beacon Capital Management bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $0. Proficio Capital Partners bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $29,000. Coconut Grove Bank increased its position in shares of UnitedHealth Group by 19.5% during the third quarter. Coconut Grove Bank now owns 736 shares of the healthcare conglomerate’s stock valued at $103,000 after purchasing an additional 120 shares during the period. First Personal Financial Services increased its position in shares of UnitedHealth Group by 36.9% during the third quarter. First Personal Financial Services now owns 742 shares of the healthcare conglomerate’s stock valued at $104,000 after purchasing an additional 200 shares during the period. Finally, Patriot Financial Group Insurance Agency LLC increased its position in shares of UnitedHealth Group by 1,722.9% during the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after purchasing an additional 603 shares during the period. Institutional investors and hedge funds own 86.11% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.